![Guy MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guy MacDonald
Voorzitter bij
SCYNEXIS, INC.
Vermogen: 71 205 $ op 31-05-2026
Profiel
Mr. Guy MacDonald is a Chairman at SCYNEXIS, Inc. Mr. MacDonald was previously employed as an Executive Vice President-Operations by Idenix Pharmaceuticals LLC, a Vice President-Anti Infective & Hospital Products by Merck & Co., Inc., and a Chairman by Spring Bank Pharmaceuticals, Inc. He also served on the board at Tetraphase Pharmaceuticals, Inc. He received his undergraduate degree from the University Of Dundee.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SCYNEXIS, INC. 0,13% | 26-06-2026 | 101.000 ( 0,13% ) | 71 205 $ | 31-05-2026 |
Actieve functies van Guy MacDonald
| Bedrijven | Functie | Begin |
|---|---|---|
| SCYNEXIS, INC. | Voorzitter | 04-06-2015 |
Eerdere bekende functies van Guy MacDonald
| Bedrijven | Functie | Einde |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Algemeen Directeur | 01-08-2019 |
| SPRING BANK PHARMACEUTICALS, INC. | Voorzitter | 17-08-2015 |
| IDENIX PHARMACEUTICALS INC | Operationeel Directeur | 01-01-2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Guy MacDonald
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
85
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
